Product Details for ANDA 075939
CIPROFLOXACIN HYDROCHLORIDE (CIPROFLOXACIN HYDROCHLORIDE)
EQ 250MG BASE
Marketing Status: Prescription
EQ 500MG BASE
Marketing Status: Prescription
EQ 750MG BASE
Marketing Status: Prescription
EQ 100MG BASE
Marketing Status: Discontinued
EQ 250MG BASE
Marketing Status: Prescription
Active Ingredient: CIPROFLOXACIN HYDROCHLORIDE
Proprietary Name: CIPROFLOXACIN HYDROCHLORIDE
Dosage Form; Route of Administration: TABLET; ORAL
Strength: EQ 250MG BASE
Reference Listed Drug: No
Reference Standard: No
TE Code: AB
Application Number: A075939
Product Number: 002
Approval Date: Jun 9, 2004
Applicant Holder Full Name: AMNEAL PHARMACEUTICALS LLC
Marketing Status: Prescription
Patent and Exclusivity Information
CIPROFLOXACIN HYDROCHLORIDE (CIPROFLOXACIN HYDROCHLORIDE)
Proprietary Name: CIPROFLOXACIN HYDROCHLORIDE
Dosage Form; Route of Administration: TABLET; ORAL
Strength: EQ 250MG BASE
Reference Listed Drug: No
Reference Standard: No
TE Code: AB
Application Number: A075939
Product Number: 002
Approval Date: Jun 9, 2004
Applicant Holder Full Name: AMNEAL PHARMACEUTICALS LLC
Marketing Status: Prescription
Patent and Exclusivity Information
EQ 500MG BASE
Marketing Status: Prescription
Active Ingredient: CIPROFLOXACIN HYDROCHLORIDE
Proprietary Name: CIPROFLOXACIN HYDROCHLORIDE
Dosage Form; Route of Administration: TABLET; ORAL
Strength: EQ 500MG BASE
Reference Listed Drug: No
Reference Standard: No
TE Code: AB
Application Number: A075939
Product Number: 003
Approval Date: Jun 9, 2004
Applicant Holder Full Name: AMNEAL PHARMACEUTICALS LLC
Marketing Status: Prescription
Patent and Exclusivity Information
CIPROFLOXACIN HYDROCHLORIDE (CIPROFLOXACIN HYDROCHLORIDE)
Proprietary Name: CIPROFLOXACIN HYDROCHLORIDE
Dosage Form; Route of Administration: TABLET; ORAL
Strength: EQ 500MG BASE
Reference Listed Drug: No
Reference Standard: No
TE Code: AB
Application Number: A075939
Product Number: 003
Approval Date: Jun 9, 2004
Applicant Holder Full Name: AMNEAL PHARMACEUTICALS LLC
Marketing Status: Prescription
Patent and Exclusivity Information
EQ 750MG BASE
Marketing Status: Prescription
Active Ingredient: CIPROFLOXACIN HYDROCHLORIDE
Proprietary Name: CIPROFLOXACIN HYDROCHLORIDE
Dosage Form; Route of Administration: TABLET; ORAL
Strength: EQ 750MG BASE
Reference Listed Drug: No
Reference Standard: No
TE Code: AB
Application Number: A075939
Product Number: 004
Approval Date: Jun 9, 2004
Applicant Holder Full Name: AMNEAL PHARMACEUTICALS LLC
Marketing Status: Prescription
Patent and Exclusivity Information
CIPROFLOXACIN HYDROCHLORIDE (CIPROFLOXACIN HYDROCHLORIDE)
Proprietary Name: CIPROFLOXACIN HYDROCHLORIDE
Dosage Form; Route of Administration: TABLET; ORAL
Strength: EQ 750MG BASE
Reference Listed Drug: No
Reference Standard: No
TE Code: AB
Application Number: A075939
Product Number: 004
Approval Date: Jun 9, 2004
Applicant Holder Full Name: AMNEAL PHARMACEUTICALS LLC
Marketing Status: Prescription
Patent and Exclusivity Information
EQ 100MG BASE
Marketing Status: Discontinued
Active Ingredient: CIPROFLOXACIN HYDROCHLORIDE
Proprietary Name: CIPROFLOXACIN HYDROCHLORIDE
Dosage Form; Route of Administration: TABLET; ORAL
Strength: EQ 100MG BASE
Reference Listed Drug: No
Reference Standard: No
TE Code:
Application Number: A075939
Product Number: 001
Approval Date: Mar 3, 2005
Applicant Holder Full Name: AMNEAL PHARMACEUTICALS LLC
Marketing Status: Discontinued
Patent and Exclusivity Information
Proprietary Name: CIPROFLOXACIN HYDROCHLORIDE
Dosage Form; Route of Administration: TABLET; ORAL
Strength: EQ 100MG BASE
Reference Listed Drug: No
Reference Standard: No
TE Code:
Application Number: A075939
Product Number: 001
Approval Date: Mar 3, 2005
Applicant Holder Full Name: AMNEAL PHARMACEUTICALS LLC
Marketing Status: Discontinued
Patent and Exclusivity Information